Indications
Cedaciclib is used to treat patients with relapsed or refractory multiple myeloma (R/R MM) who have received four or more prior lines of therapy, including proteasome inhibitors, immunomodulators, and anti-CD38 monoclonal antibodies. [1]
Let us work together to protect precious health